Global Ocular Gene Therapy Market Growth (Status and Outlook) 2026-2032

July 2026 | 95 pages | ID: G0B50E292B34EN
LP Information

Abstracts

The global Ocular Gene Therapy market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032.

United States market for Ocular Gene Therapy is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.

China market for Ocular Gene Therapy is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.

Europe market for Ocular Gene Therapy is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.

Global key Ocular Gene Therapy players cover AbbVie, MeriaGTx, Regenxbio, GenSight Biologics, Astellas, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.

LPI (LP Information)' newest research report, the ?Ocular Gene Therapy Industry Forecast? looks at past sales and reviews total world Ocular Gene Therapy sales in 2025, providing a comprehensive analysis by region and market sector of projected Ocular Gene Therapy sales for 2026 through 2032. With Ocular Gene Therapy sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Ocular Gene Therapy industry.

This Insight Report provides a comprehensive analysis of the global Ocular Gene Therapy landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Ocular Gene Therapy portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Ocular Gene Therapy market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Ocular Gene Therapy and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Ocular Gene Therapy.

This report presents a comprehensive overview, market shares, and growth opportunities of Ocular Gene Therapy market by product type, application, key players and key regions and countries.

Segmentation by Type:

• Gene Replacement Technology
• Gene Editing Technology
• Others

Segmentation by Application:

• Hospitals
• Diagnostics Centers
• Research Institutes

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

• AbbVie
• MeriaGTx
• Regenxbio
• GenSight Biologics
• Astellas
• Neurophth Therapeutics
• Innostellar Biotherapeutics
• Exegenesis Bio
• Zhongyin Technology

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Ocular Gene Therapy Market Size (2021-2032)
  2.1.2 Ocular Gene Therapy Market Size CAGR by Region (2021 VS 2025 VS 2032)
  2.1.3 World Current & Future Analysis for Ocular Gene Therapy by Country/Region (2021, 2025 & 2032)
2.2 Ocular Gene Therapy Segment by Type
  2.2.1 Gene Replacement Technology
  2.2.2 Gene Editing Technology
  2.2.3 Others
  2.2.4 Ocular Gene Therapy Market Size by Type
    2.2.4.1 Ocular Gene Therapy Market Size CAGR by Type (2021 VS 2025 VS 2032)
    2.2.4.2 Global Ocular Gene Therapy Market Size Market Share by Type (2021-2026)
2.3 Ocular Gene Therapy Segment by Application
  2.3.1 Hospitals
  2.3.2 Diagnostics Centers
  2.3.3 Research Institutes
  2.3.4 Ocular Gene Therapy Market Size by Application
    2.3.4.1 Ocular Gene Therapy Market Size CAGR by Application (2021 VS 2025 VS 2032)
    2.3.4.2 Global Ocular Gene Therapy Market Size Market Share by Application (2021-2026)

3 OCULAR GENE THERAPY MARKET SIZE BY PLAYER

3.1 Ocular Gene Therapy Market Size Market Share by Player
  3.1.1 Global Ocular Gene Therapy Revenue by Player (2021-2026)
  3.1.2 Global Ocular Gene Therapy Revenue Market Share by Player (2021-2026)
3.2 Global Ocular Gene Therapy Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 OCULAR GENE THERAPY BY REGION

4.1 Ocular Gene Therapy Market Size by Region (2021-2026)
4.2 Global Ocular Gene Therapy Annual Revenue by Country/Region (2021-2026)
4.3 Americas Ocular Gene Therapy Market Size Growth (2021-2026)
4.4 APAC Ocular Gene Therapy Market Size Growth (2021-2026)
4.5 Europe Ocular Gene Therapy Market Size Growth (2021-2026)
4.6 Middle East & Africa Ocular Gene Therapy Market Size Growth (2021-2026)

5 AMERICAS

5.1 Americas Ocular Gene Therapy Market Size by Country (2021-2026)
5.2 Americas Ocular Gene Therapy Market Size by Type (2021-2026)
5.3 Americas Ocular Gene Therapy Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Ocular Gene Therapy Market Size by Region (2021-2026)
6.2 APAC Ocular Gene Therapy Market Size by Type (2021-2026)
6.3 APAC Ocular Gene Therapy Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe Ocular Gene Therapy Market Size by Country (2021-2026)
7.2 Europe Ocular Gene Therapy Market Size by Type (2021-2026)
7.3 Europe Ocular Gene Therapy Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Ocular Gene Therapy by Region (2021-2026)
8.2 Middle East & Africa Ocular Gene Therapy Market Size by Type (2021-2026)
8.3 Middle East & Africa Ocular Gene Therapy Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL OCULAR GENE THERAPY MARKET FORECAST

10.1 Global Ocular Gene Therapy Forecast by Region (2027-2032)
  10.1.1 Global Ocular Gene Therapy Forecast by Region (2027-2032)
  10.1.2 Americas Ocular Gene Therapy Forecast
  10.1.3 APAC Ocular Gene Therapy Forecast
  10.1.4 Europe Ocular Gene Therapy Forecast
  10.1.5 Middle East & Africa Ocular Gene Therapy Forecast
10.2 Americas Ocular Gene Therapy Forecast by Country (2027-2032)
  10.2.1 United States Market Ocular Gene Therapy Forecast
  10.2.2 Canada Market Ocular Gene Therapy Forecast
  10.2.3 Mexico Market Ocular Gene Therapy Forecast
  10.2.4 Brazil Market Ocular Gene Therapy Forecast
10.3 APAC Ocular Gene Therapy Forecast by Region (2027-2032)
  10.3.1 China Ocular Gene Therapy Market Forecast
  10.3.2 Japan Market Ocular Gene Therapy Forecast
  10.3.3 Korea Market Ocular Gene Therapy Forecast
  10.3.4 Southeast Asia Market Ocular Gene Therapy Forecast
  10.3.5 India Market Ocular Gene Therapy Forecast
  10.3.6 Australia Market Ocular Gene Therapy Forecast
10.4 Europe Ocular Gene Therapy Forecast by Country (2027-2032)
  10.4.1 Germany Market Ocular Gene Therapy Forecast
  10.4.2 France Market Ocular Gene Therapy Forecast
  10.4.3 UK Market Ocular Gene Therapy Forecast
  10.4.4 Italy Market Ocular Gene Therapy Forecast
  10.4.5 Russia Market Ocular Gene Therapy Forecast
10.5 Middle East & Africa Ocular Gene Therapy Forecast by Region (2027-2032)
  10.5.1 Egypt Market Ocular Gene Therapy Forecast
  10.5.2 South Africa Market Ocular Gene Therapy Forecast
  10.5.3 Israel Market Ocular Gene Therapy Forecast
  10.5.4 Turkey Market Ocular Gene Therapy Forecast
10.6 Global Ocular Gene Therapy Forecast by Type (2027-2032)
10.7 Global Ocular Gene Therapy Forecast by Application (2027-2032)
  10.7.1 GCC Countries Market Ocular Gene Therapy Forecast

11 KEY PLAYERS ANALYSIS

11.1 AbbVie
  11.1.1 AbbVie Company Information
  11.1.2 AbbVie Ocular Gene Therapy Product Offered
  11.1.3 AbbVie Ocular Gene Therapy Revenue, Gross Margin and Market Share (2021-2026)
  11.1.4 AbbVie Main Business Overview
  11.1.5 AbbVie Latest Developments
11.2 MeriaGTx
  11.2.1 MeriaGTx Company Information
  11.2.2 MeriaGTx Ocular Gene Therapy Product Offered
  11.2.3 MeriaGTx Ocular Gene Therapy Revenue, Gross Margin and Market Share (2021-2026)
  11.2.4 MeriaGTx Main Business Overview
  11.2.5 MeriaGTx Latest Developments
11.3 Regenxbio
  11.3.1 Regenxbio Company Information
  11.3.2 Regenxbio Ocular Gene Therapy Product Offered
  11.3.3 Regenxbio Ocular Gene Therapy Revenue, Gross Margin and Market Share (2021-2026)
  11.3.4 Regenxbio Main Business Overview
  11.3.5 Regenxbio Latest Developments
11.4 GenSight Biologics
  11.4.1 GenSight Biologics Company Information
  11.4.2 GenSight Biologics Ocular Gene Therapy Product Offered
  11.4.3 GenSight Biologics Ocular Gene Therapy Revenue, Gross Margin and Market Share (2021-2026)
  11.4.4 GenSight Biologics Main Business Overview
  11.4.5 GenSight Biologics Latest Developments
11.5 Astellas
  11.5.1 Astellas Company Information
  11.5.2 Astellas Ocular Gene Therapy Product Offered
  11.5.3 Astellas Ocular Gene Therapy Revenue, Gross Margin and Market Share (2021-2026)
  11.5.4 Astellas Main Business Overview
  11.5.5 Astellas Latest Developments
11.6 Neurophth Therapeutics
  11.6.1 Neurophth Therapeutics Company Information
  11.6.2 Neurophth Therapeutics Ocular Gene Therapy Product Offered
  11.6.3 Neurophth Therapeutics Ocular Gene Therapy Revenue, Gross Margin and Market Share (2021-2026)
  11.6.4 Neurophth Therapeutics Main Business Overview
  11.6.5 Neurophth Therapeutics Latest Developments
11.7 Innostellar Biotherapeutics
  11.7.1 Innostellar Biotherapeutics Company Information
  11.7.2 Innostellar Biotherapeutics Ocular Gene Therapy Product Offered
  11.7.3 Innostellar Biotherapeutics Ocular Gene Therapy Revenue, Gross Margin and Market Share (2021-2026)
  11.7.4 Innostellar Biotherapeutics Main Business Overview
  11.7.5 Innostellar Biotherapeutics Latest Developments
11.8 Exegenesis Bio
  11.8.1 Exegenesis Bio Company Information
  11.8.2 Exegenesis Bio Ocular Gene Therapy Product Offered
  11.8.3 Exegenesis Bio Ocular Gene Therapy Revenue, Gross Margin and Market Share (2021-2026)
  11.8.4 Exegenesis Bio Main Business Overview
  11.8.5 Exegenesis Bio Latest Developments
11.9 Zhongyin Technology
  11.9.1 Zhongyin Technology Company Information
  11.9.2 Zhongyin Technology Ocular Gene Therapy Product Offered
  11.9.3 Zhongyin Technology Ocular Gene Therapy Revenue, Gross Margin and Market Share (2021-2026)
  11.9.4 Zhongyin Technology Main Business Overview
  11.9.5 Zhongyin Technology Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Ocular Gene Therapy Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. Ocular Gene Therapy Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Gene Replacement Technology
Table 4. Major Players of Gene Editing Technology
Table 5. Major Players of Others
Table 6. Ocular Gene Therapy Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 7. Global Ocular Gene Therapy Market Size by Type (2021-2026) & ($ millions)
Table 8. Global Ocular Gene Therapy Market Size Market Share by Type (2021-2026)
Table 9. Ocular Gene Therapy Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 10. Global Ocular Gene Therapy Market Size by Application (2021-2026) & ($ millions)
Table 11. Global Ocular Gene Therapy Market Size Market Share by Application (2021-2026)
Table 12. Global Ocular Gene Therapy Revenue by Player (2021-2026) & ($ millions)
Table 13. Global Ocular Gene Therapy Revenue Market Share by Player (2021-2026)
Table 14. Ocular Gene Therapy Key Players Head office and Products Offered
Table 15. Ocular Gene Therapy Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global Ocular Gene Therapy Market Size by Region (2021-2026) & ($ millions)
Table 19. Global Ocular Gene Therapy Market Size Market Share by Region (2021-2026)
Table 20. Global Ocular Gene Therapy Revenue by Country/Region (2021-2026) & ($ millions)
Table 21. Global Ocular Gene Therapy Revenue Market Share by Country/Region (2021-2026)
Table 22. Americas Ocular Gene Therapy Market Size by Country (2021-2026) & ($ millions)
Table 23. Americas Ocular Gene Therapy Market Size Market Share by Country (2021-2026)
Table 24. Americas Ocular Gene Therapy Market Size by Type (2021-2026) & ($ millions)
Table 25. Americas Ocular Gene Therapy Market Size Market Share by Type (2021-2026)
Table 26. Americas Ocular Gene Therapy Market Size by Application (2021-2026) & ($ millions)
Table 27. Americas Ocular Gene Therapy Market Size Market Share by Application (2021-2026)
Table 28. APAC Ocular Gene Therapy Market Size by Region (2021-2026) & ($ millions)
Table 29. APAC Ocular Gene Therapy Market Size Market Share by Region (2021-2026)
Table 30. APAC Ocular Gene Therapy Market Size by Type (2021-2026) & ($ millions)
Table 31. APAC Ocular Gene Therapy Market Size by Application (2021-2026) & ($ millions)
Table 32. Europe Ocular Gene Therapy Market Size by Country (2021-2026) & ($ millions)
Table 33. Europe Ocular Gene Therapy Market Size Market Share by Country (2021-2026)
Table 34. Europe Ocular Gene Therapy Market Size by Type (2021-2026) & ($ millions)
Table 35. Europe Ocular Gene Therapy Market Size by Application (2021-2026) & ($ millions)
Table 36. Middle East & Africa Ocular Gene Therapy Market Size by Region (2021-2026) & ($ millions)
Table 37. Middle East & Africa Ocular Gene Therapy Market Size by Type (2021-2026) & ($ millions)
Table 38. Middle East & Africa Ocular Gene Therapy Market Size by Application (2021-2026) & ($ millions)
Table 39. Key Market Drivers & Growth Opportunities of Ocular Gene Therapy
Table 40. Key Market Challenges & Risks of Ocular Gene Therapy
Table 41. Key Industry Trends of Ocular Gene Therapy
Table 42. Global Ocular Gene Therapy Market Size Forecast by Region (2027-2032) & ($ millions)
Table 43. Global Ocular Gene Therapy Market Size Market Share Forecast by Region (2027-2032)
Table 44. Global Ocular Gene Therapy Market Size Forecast by Type (2027-2032) & ($ millions)
Table 45. Global Ocular Gene Therapy Market Size Forecast by Application (2027-2032) & ($ millions)
Table 46. AbbVie Details, Company Type, Ocular Gene Therapy Area Served and Its Competitors
Table 47. AbbVie Ocular Gene Therapy Product Offered
Table 48. AbbVie Ocular Gene Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 49. AbbVie Main Business
Table 50. AbbVie Latest Developments
Table 51. MeriaGTx Details, Company Type, Ocular Gene Therapy Area Served and Its Competitors
Table 52. MeriaGTx Ocular Gene Therapy Product Offered
Table 53. MeriaGTx Ocular Gene Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 54. MeriaGTx Main Business
Table 55. MeriaGTx Latest Developments
Table 56. Regenxbio Details, Company Type, Ocular Gene Therapy Area Served and Its Competitors
Table 57. Regenxbio Ocular Gene Therapy Product Offered
Table 58. Regenxbio Ocular Gene Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 59. Regenxbio Main Business
Table 60. Regenxbio Latest Developments
Table 61. GenSight Biologics Details, Company Type, Ocular Gene Therapy Area Served and Its Competitors
Table 62. GenSight Biologics Ocular Gene Therapy Product Offered
Table 63. GenSight Biologics Ocular Gene Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 64. GenSight Biologics Main Business
Table 65. GenSight Biologics Latest Developments
Table 66. Astellas Details, Company Type, Ocular Gene Therapy Area Served and Its Competitors
Table 67. Astellas Ocular Gene Therapy Product Offered
Table 68. Astellas Ocular Gene Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 69. Astellas Main Business
Table 70. Astellas Latest Developments
Table 71. Neurophth Therapeutics Details, Company Type, Ocular Gene Therapy Area Served and Its Competitors
Table 72. Neurophth Therapeutics Ocular Gene Therapy Product Offered
Table 73. Neurophth Therapeutics Ocular Gene Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 74. Neurophth Therapeutics Main Business
Table 75. Neurophth Therapeutics Latest Developments
Table 76. Innostellar Biotherapeutics Details, Company Type, Ocular Gene Therapy Area Served and Its Competitors
Table 77. Innostellar Biotherapeutics Ocular Gene Therapy Product Offered
Table 78. Innostellar Biotherapeutics Ocular Gene Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 79. Innostellar Biotherapeutics Main Business
Table 80. Innostellar Biotherapeutics Latest Developments
Table 81. Exegenesis Bio Details, Company Type, Ocular Gene Therapy Area Served and Its Competitors
Table 82. Exegenesis Bio Ocular Gene Therapy Product Offered
Table 83. Exegenesis Bio Ocular Gene Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 84. Exegenesis Bio Main Business
Table 85. Exegenesis Bio Latest Developments
Table 86. Zhongyin Technology Details, Company Type, Ocular Gene Therapy Area Served and Its Competitors
Table 87. Zhongyin Technology Ocular Gene Therapy Product Offered
Table 88. Zhongyin Technology Ocular Gene Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 89. Zhongyin Technology Main Business
Table 90. Zhongyin Technology Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Ocular Gene Therapy Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Ocular Gene Therapy Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. Ocular Gene Therapy Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. Ocular Gene Therapy Sales Market Share by Country/Region (2025)
Figure 8. Ocular Gene Therapy Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global Ocular Gene Therapy Market Size Market Share by Type in 2025
Figure 10. Ocular Gene Therapy in Hospitals
Figure 11. Global Ocular Gene Therapy Market: Hospitals (2021-2026) & ($ millions)
Figure 12. Ocular Gene Therapy in Diagnostics Centers
Figure 13. Global Ocular Gene Therapy Market: Diagnostics Centers (2021-2026) & ($ millions)
Figure 14. Ocular Gene Therapy in Research Institutes
Figure 15. Global Ocular Gene Therapy Market: Research Institutes (2021-2026) & ($ millions)
Figure 16. Global Ocular Gene Therapy Market Size Market Share by Application in 2025
Figure 17. Global Ocular Gene Therapy Revenue Market Share by Player in 2025
Figure 18. Global Ocular Gene Therapy Market Size Market Share by Region (2021-2026)
Figure 19. Americas Ocular Gene Therapy Market Size 2021-2026 ($ millions)
Figure 20. APAC Ocular Gene Therapy Market Size 2021-2026 ($ millions)
Figure 21. Europe Ocular Gene Therapy Market Size 2021-2026 ($ millions)
Figure 22. Middle East & Africa Ocular Gene Therapy Market Size 2021-2026 ($ millions)
Figure 23. Americas Ocular Gene Therapy Value Market Share by Country in 2025
Figure 24. United States Ocular Gene Therapy Market Size Growth 2021-2026 ($ millions)
Figure 25. Canada Ocular Gene Therapy Market Size Growth 2021-2026 ($ millions)
Figure 26. Mexico Ocular Gene Therapy Market Size Growth 2021-2026 ($ millions)
Figure 27. Brazil Ocular Gene Therapy Market Size Growth 2021-2026 ($ millions)
Figure 28. APAC Ocular Gene Therapy Market Size Market Share by Region in 2025
Figure 29. APAC Ocular Gene Therapy Market Size Market Share by Type (2021-2026)
Figure 30. APAC Ocular Gene Therapy Market Size Market Share by Application (2021-2026)
Figure 31. China Ocular Gene Therapy Market Size Growth 2021-2026 ($ millions)
Figure 32. Japan Ocular Gene Therapy Market Size Growth 2021-2026 ($ millions)
Figure 33. South Korea Ocular Gene Therapy Market Size Growth 2021-2026 ($ millions)
Figure 34. Southeast Asia Ocular Gene Therapy Market Size Growth 2021-2026 ($ millions)
Figure 35. India Ocular Gene Therapy Market Size Growth 2021-2026 ($ millions)
Figure 36. Australia Ocular Gene Therapy Market Size Growth 2021-2026 ($ millions)
Figure 37. Europe Ocular Gene Therapy Market Size Market Share by Country in 2025
Figure 38. Europe Ocular Gene Therapy Market Size Market Share by Type (2021-2026)
Figure 39. Europe Ocular Gene Therapy Market Size Market Share by Application (2021-2026)
Figure 40. Germany Ocular Gene Therapy Market Size Growth 2021-2026 ($ millions)
Figure 41. France Ocular Gene Therapy Market Size Growth 2021-2026 ($ millions)
Figure 42. UK Ocular Gene Therapy Market Size Growth 2021-2026 ($ millions)
Figure 43. Italy Ocular Gene Therapy Market Size Growth 2021-2026 ($ millions)
Figure 44. Russia Ocular Gene Therapy Market Size Growth 2021-2026 ($ millions)
Figure 45. Middle East & Africa Ocular Gene Therapy Market Size Market Share by Region (2021-2026)
Figure 46. Middle East & Africa Ocular Gene Therapy Market Size Market Share by Type (2021-2026)
Figure 47. Middle East & Africa Ocular Gene Therapy Market Size Market Share by Application (2021-2026)
Figure 48. Egypt Ocular Gene Therapy Market Size Growth 2021-2026 ($ millions)
Figure 49. South Africa Ocular Gene Therapy Market Size Growth 2021-2026 ($ millions)
Figure 50. Israel Ocular Gene Therapy Market Size Growth 2021-2026 ($ millions)
Figure 51. Turkey Ocular Gene Therapy Market Size Growth 2021-2026 ($ millions)
Figure 52. GCC Countries Ocular Gene Therapy Market Size Growth 2021-2026 ($ millions)
Figure 53. Americas Ocular Gene Therapy Market Size 2027-2032 ($ millions)
Figure 54. APAC Ocular Gene Therapy Market Size 2027-2032 ($ millions)
Figure 55. Europe Ocular Gene Therapy Market Size 2027-2032 ($ millions)
Figure 56. Middle East & Africa Ocular Gene Therapy Market Size 2027-2032 ($ millions)
Figure 57. United States Ocular Gene Therapy Market Size 2027-2032 ($ millions)
Figure 58. Canada Ocular Gene Therapy Market Size 2027-2032 ($ millions)
Figure 59. Mexico Ocular Gene Therapy Market Size 2027-2032 ($ millions)
Figure 60. Brazil Ocular Gene Therapy Market Size 2027-2032 ($ millions)
Figure 61. China Ocular Gene Therapy Market Size 2027-2032 ($ millions)
Figure 62. Japan Ocular Gene Therapy Market Size 2027-2032 ($ millions)
Figure 63. Korea Ocular Gene Therapy Market Size 2027-2032 ($ millions)
Figure 64. Southeast Asia Ocular Gene Therapy Market Size 2027-2032 ($ millions)
Figure 65. India Ocular Gene Therapy Market Size 2027-2032 ($ millions)
Figure 66. Australia Ocular Gene Therapy Market Size 2027-2032 ($ millions)
Figure 67. Germany Ocular Gene Therapy Market Size 2027-2032 ($ millions)
Figure 68. France Ocular Gene Therapy Market Size 2027-2032 ($ millions)
Figure 69. UK Ocular Gene Therapy Market Size 2027-2032 ($ millions)
Figure 70. Italy Ocular Gene Therapy Market Size 2027-2032 ($ millions)
Figure 71. Russia Ocular Gene Therapy Market Size 2027-2032 ($ millions)
Figure 72. Egypt Ocular Gene Therapy Market Size 2027-2032 ($ millions)
Figure 73. South Africa Ocular Gene Therapy Market Size 2027-2032 ($ millions)
Figure 74. Israel Ocular Gene Therapy Market Size 2027-2032 ($ millions)
Figure 75. Turkey Ocular Gene Therapy Market Size 2027-2032 ($ millions)
Figure 76. Global Ocular Gene Therapy Market Size Market Share Forecast by Type (2027-2032)
Figure 77. Global Ocular Gene Therapy Market Size Market Share Forecast by Application (2027-2032)
Figure 78. GCC Countries Ocular Gene Therapy Market Size 2027-2032 ($ millions)